Led by Dr Karen Shaw, BTRU PPI Lead from the University of Birmingham, and co-authored with Patient Partners, BTRU in Precision Cellular Therapeutics has released an article in The Lancet which discusses current challenges, useful resources and future directions for patient and public involvement in translational medicine.
The commentary highlights the importance of PPI activities in translational projects and the impact that such engagement has on bridging the gap between preclinical research and clinical implementation.
Please find the details of the article below:
Karen Shaw, Melanie Calvert, Persephone Borrow, Evelyn Chakera, Ronjon Chakraverty, Sarah Hughes, Foram Khatsuria, Francesca Kinsella, Christel McMullan, Julie Richardson-Abraham, Vlada Yarosh, Olalekan Lee Aiyegbusi, “Integrating patient and public involvement and engagement in translational medicine”, The Lancet, Volume 404, Issue 10455, 828 – 831, https://doi.org/10.1016/S0140-6736(24)01552-6